NEU neuren pharmaceuticals limited

Ann: 2024 results - A$166m comprehensive income for shareholders, page-5

  1. 34,438 Posts.
    lightbulb Created with Sketch. 9327
    $359m pro-forma cash! That's after tax amount.
    2025 annual royalties will be around $65m.
    Europe sales may come as early as Q2, 2025, expected to be approved in Q1, 2026.
    Canada sales in Q3,2025.
    Annual royalties for next year, is likely to reach $100m, imo.

    Cash burn rate might not as high as I expected,
    2024 R&D: $33m
    Corporate & administrative: $4.7m
    Total: $37.7m for the year.
    Last edited by 8horse: 28/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.000(0.00%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.61 $12.68 $12.32 $7.219M 577.9K

Buyers (Bids)

No. Vol. Price($)
1 2968 $12.51
 

Sellers (Offers)

Price($) Vol. No.
$12.57 540 1
View Market Depth
Last trade - 16.16pm 25/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.